2011

CLINICAL CHANGES IN SCHIZOPHRENIA, Issue 6
Case Study: The Pursuit of Treatment Goals in Schizophrenia
Psychosocial interventions can support pharmacotherapy in the management of schizophrenia and are important tools in the psychiatrist's armamentarium. This case study highlights a patient who requires an integrated approach to treatment.
Faculty: Richard H. Weisler, MD, and Henry A. Nasrallah, MD
This newsletter is sponsored by Sunovion Pharmaceuticals Inc.
July 2011
Read more

CLINICAL CHANGES IN SCHIZOPHRENIA, Issue 5
Case Study: The Hippocratic Oath in Psychiatry
Physical well-being has become a major focus in the treatment of patients with schizophrenia. This newsletter presents the case of a patient with schizophrenia who experiences side effects during treatment.
Faculty: Brian Kirkpatrick, MD, and Henry A. Nasrallah, MD
This newsletter is sponsored by Sunovion Pharmaceuticals Inc.
June 2011
Read more

CLINICAL CHANGES IN SCHIZOPHRENIA, Issue 4
Case Study: The Importance of Being Early
Symptoms of schizophrenia may be present for several years before patients receive care. This newsletter presents the case of a man who exhibits increasingly severe and incapacitating symptoms. It also discusses the critical importance of appropriate diagnosis and treatment.
Faculty: Mark Zetin, MD, and Henry A. Nasrallah, MD
This newsletter is sponsored by Sunovion Pharmaceuticals Inc.
May 2011
Read more

CLINICAL CHANGES IN SCHIZOPHRENIA, Issue 3
Case Study: Are We There Yet? The Road to Discovery of Antipsychotics
Research has led to a greater understanding of schizophrenia and its treatment. This newsletter presents the case of a middle-aged man who has been treated with several antipsychotic agents over the course of two decades. Faced with undesirable effects of the patient's current medication, the psychiatrist seeks to balance efficacy and safety in this case.
Faculty: Steven G. Potkin, MD, and Henry A. Nasrallah, MD
This newsletter is sponsored by Sunovion Pharmaceuticals Inc.
April 2011
Read more

CLINICAL CHANGES IN SCHIZOPHRENIA, Issue 2
Case Study: When More Is Not Better—Polypharmacy in the Treatment of Schizophrenia
Polypharmacy is a common problem in the treatment of schizophrenia. This case explores why this practice is still common despite the fact that treatment guidelines emphasize monotherapy. The case presentation features a patient whose psychiatrist is struggling with selection of the right medication.
Faculty: Joseph McEvoy, MD, and Henry A. Nasrallah, MD
This newsletter is sponsored by Sunovion Pharmaceuticals Inc.
March 2011
Read more

CLINICAL CHANGES IN SCHIZOPHRENIA, Issue 1
Case Study: Sporadic Adherence—The Psychiatrist as Pharmacologic Matchmaker
Nonadherence to medication is a widespread problem in the treatment of schizophrenia. This newsletter examines the case of a patient who was initially treated successfully but recently has become delusional and refuses to take her medication. Potential approaches to addressing this situation directly with the patient are explored.
Faculty: Leslie Citrome, MD, MPH, and Henry A. Nasrallah, MD
This newsletter is sponsored by Sunovion Pharmaceuticals Inc.
February 2011
Read more